Literature DB >> 12808120

Origin and development of the precursor lesions in experimental pancreatic cancer in rats.

Dale E Bockman1, Junchao Guo, Peter Büchler, Michael W Müller, Frank Bergmann, Helmut Friess.   

Abstract

Notwithstanding the importance of understanding how pancreatic ductal adenocarcinoma develops, the process remains controversial. A key question is whether the cells of origin of the tubular complexes that constitute precursor lesions are derived from a single cell type or from multiple types. Suggestions that they arise solely from centroacinar cells or ductal cells have been based on inference due to their morphologic appearance in tissue from patients or investigation of limited numbers of tubular complexes in animal models later in the carcinogenic process. The present study establishes clearly that two steps are involved; rapid transdifferentiation to produce tubular complexes followed later by transformation of the component cells. Animals were killed at intervals beginning 1 day after implantation of the carcinogen dimethylbenzanthracene. Transdifferentiation of acinar cells to ductal cells does not require cell division. Transition of lobules to tubular complexes begins by 2 days after implantation of carcinogen. Within 4 days after implantation well-developed tubular complexes are present. Islets participate in the process. Ductal adenocarcinoma is observed by 1 month after implantation of carcinogen. Chymotrypsin and cytokeratin localized by immunocytochemistry indicate acinar and ductal cell characteristics. Acino-ductal transdifferentiation persists in carcinogen-implanted animals, but not in controls implanted with sodium chloride crystals or subjected to sham implantation. The precursor lesions (tubular complexes) are formed by the transdifferentiation of acinar cells and to a lesser extent islet cells, with the incorporation of the duct cells pre-existing in the lobules. Therefore, cells that at one time were acinar cells, islet cells, and duct cells, provide the precursor cells for the ductal adenocarcinoma that develops from tubular complexes. The results raise the question whether the transdifferentiated cells in the tubular complexes of patients with chronic pancreatitis are more susceptible to carcinogenic influences, resulting in the increased rate of pancreatic cancer.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12808120     DOI: 10.1097/01.lab.0000074918.31303.5a

Source DB:  PubMed          Journal:  Lab Invest        ISSN: 0023-6837            Impact factor:   5.662


  28 in total

1.  A Revised Classification System and Recommendations From the Baltimore Consensus Meeting for Neoplastic Precursor Lesions in the Pancreas.

Authors:  Olca Basturk; Seung-Mo Hong; Laura D Wood; N Volkan Adsay; Jorge Albores-Saavedra; Andrew V Biankin; Lodewijk A A Brosens; Noriyoshi Fukushima; Michael Goggins; Ralph H Hruban; Yo Kato; David S Klimstra; Günter Klöppel; Alyssa Krasinskas; Daniel S Longnecker; Hanno Matthaei; G Johan A Offerhaus; Michio Shimizu; Kyoichi Takaori; Benoit Terris; Shinichi Yachida; Irene Esposito; Toru Furukawa
Journal:  Am J Surg Pathol       Date:  2015-12       Impact factor: 6.394

2.  Role of the ductal transcription factors HNF6 and Sox9 in pancreatic acinar-to-ductal metaplasia.

Authors:  Pierre-Paul Prévot; Alexandru Simion; Adrien Grimont; Marta Colletti; Abed Khalaileh; Géraldine Van den Steen; Christine Sempoux; Xiaobo Xu; Véronique Roelants; Jacob Hald; Luc Bertrand; Harry Heimberg; Stephen F Konieczny; Yuval Dor; Frédéric P Lemaigre; Patrick Jacquemin
Journal:  Gut       Date:  2012-01-22       Impact factor: 23.059

3.  Mist1 regulates pancreatic acinar cell proliferation through p21 CIP1/WAF1.

Authors:  Di Jia; Yan Sun; Stephen F Konieczny
Journal:  Gastroenterology       Date:  2008-07-31       Impact factor: 22.682

Review 4.  The pathobiological impact of cigarette smoke on pancreatic cancer development (review).

Authors:  Uwe A Wittel; Navneet Momi; Gabriel Seifert; Thorsten Wiech; Ulrich T Hopt; Surinder K Batra
Journal:  Int J Oncol       Date:  2012-03-23       Impact factor: 5.650

5.  Valproic Acid Limits Pancreatic Recovery after Pancreatitis by Inhibiting Histone Deacetylases and Preventing Acinar Redifferentiation Programs.

Authors:  John F Eisses; Angela Criscimanna; Zachary R Dionise; Abrahim I Orabi; Tanveer A Javed; Sheharyar Sarwar; Shunqian Jin; Lili Zhou; Sucha Singh; Minakshi Poddar; Amy W Davis; Akif Burak Tosun; John A Ozolek; Mark E Lowe; Satdarshan P Monga; Gustavo K Rohde; Farzad Esni; Sohail Z Husain
Journal:  Am J Pathol       Date:  2015-10-23       Impact factor: 4.307

6.  Expression of cholecystokinin-2/gastrin receptor in the murine pancreas modulates cell adhesion and cell differentiation in vivo.

Authors:  Christiane Bierkamp; Stéphanie Bonhoure; Anne Mathieu; Pascal Clerc; Daniel Fourmy; Lucien Pradayrol; Catherine Seva; Marlène Dufresne
Journal:  Am J Pathol       Date:  2004-12       Impact factor: 4.307

7.  Progressive metaplastic and dysplastic changes in mouse pancreas induced by cyclooxygenase-2 overexpression.

Authors:  Jennifer Kl Colby; Russell D Klein; Mark J McArthur; Claudio J Conti; Kaoru Kiguchi; Toru Kawamoto; Penny K Riggs; Amy I Pavone; Janet Sawicki; Susan M Fischer
Journal:  Neoplasia       Date:  2008-08       Impact factor: 5.715

8.  Prospects and challenges for islet regeneration as a treatment for diabetes: a review of islet neogenesis associated protein.

Authors:  Alexander Fleming; Lawrence Rosenberg
Journal:  J Diabetes Sci Technol       Date:  2007-03

Review 9.  Nonproliferative and Proliferative Lesions of the Gastrointestinal Tract, Pancreas and Salivary Glands of the Rat and Mouse.

Authors:  Thomas Nolte; Patricia Brander-Weber; Charles Dangler; Ulrich Deschl; Michael R Elwell; Peter Greaves; Richard Hailey; Michael W Leach; Arun R Pandiri; Arlin Rogers; Cynthia C Shackelford; Andrew Spencer; Takuji Tanaka; Jerrold M Ward
Journal:  J Toxicol Pathol       Date:  2016-02-13       Impact factor: 1.628

Review 10.  Overview of exocrine pancreatic pathobiology.

Authors:  Arun R Pandiri
Journal:  Toxicol Pathol       Date:  2013-11-03       Impact factor: 1.902

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.